Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Adaptive Geospatial Surveillance System for Antimalarial Drug Resistance

Gupta A. et al, (2025)

Efficacy of artemisinin-based combination therapy (ACT) in people living with HIV (PLHIV) diagnosed with uncomplicated Plasmodium falciparum malaria in Africa: a WWARN systematic review.

Takyi A. et al, (2025), Malar J, 24

Safety and efficacy of single-dose primaquine to interrupt Plasmodium falciparum malaria transmission in children compared with adults: a systematic review and individual patient data meta-analysis.

Yilma D. et al, (2025), Lancet Infect Dis

Defining the noma research agenda.

Galli A. et al, (2025), PLoS Negl Trop Dis, 19

Wrangling Real-World Data: Optimizing Clinical Research Through Factor Selection with LASSO Regression.

Howard KA. et al, (2025), Int J Environ Res Public Health, 22

Prevalence of asymptomatic parasitaemia among household members of children under seasonal malaria chemoprevention coverage and comparison of the performance of standard rapid diagnostic tests versus ultrasensitive RDT for the detection of asymptomatic parasitaemia in Nanoro, Burkina Faso

Kambou SAE. et al, (2024), Parasitology Research, 123

Primaquine for uncomplicated Plasmodium vivax malaria in children younger than 15 years: a systematic review and individual patient data meta-analysis.

Commons RJ. et al, (2024), Lancet Child Adolesc Health, 8, 798 - 808

Non-malarial febrile illness: a systematic review of published aetiological studies and case reports from China, 1980-2015.

Ip DKM. et al, (2024), BMC Infect Dis, 24

Design, Conduct, Analysis, and Reporting of Therapeutic Efficacy Studies in Visceral Leishmaniasis: A Systematic Review of Published Reports, 2000-2021.

Dahal P. et al, (2024), Am J Trop Med Hyg, 111, 365 - 376

Quantifying anti-trypanosomal treatment effects in chronic indeterminate Chagas disease: an individual patient data meta-analysis of two proof of concept trials

Watson JA. et al, (2024)

Factors Affecting Integration of an Early Warning System for Antimalarial Drug Resistance within a Routine Surveillance System in a Pre-elimination Setting in Sub-Saharan Africa

Kagoro FM. et al, (2024)

Blood transfusion in the care of patients with visceral leishmaniasis: a review of practices in therapeutic efficacy studies.

Dahal P. et al, (2024), Trans R Soc Trop Med Hyg

Systematic Review and Geospatial Modeling of Molecular Markers of Resistance to Artemisinins and Sulfadoxine-Pyrimethamine in Plasmodium falciparum in India.

Nain M. et al, (2024), Am J Trop Med Hyg, 110, 910 - 920

Comparison of WHO versus national COVID-19 therapeutic guidelines across the world: not exactly a perfect match.

Cokljat M. et al, (2024), BMJ Glob Health, 9

Does acute malnutrition in young children increase the risk of treatment failure following artemisinin-based combination therapy? A WWARN individual patient data meta-analysis.

WWARN ACT Malaria and Malnutrition Study Group None., (2024), Lancet Glob Health, 12, e631 - e640

Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: A systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform.

Singh-Phulgenda S. et al, (2024), PLoS Negl Trop Dis, 18

Spatio-temporal spread of artemisinin resistance in Southeast Asia.

Flegg JA. et al, (2024), PLoS Comput Biol, 20

Estimating the proportion of relapse following treatment of Visceral Leishmaniasis: meta-analysis using Infectious Diseases Data Observatory (IDDO) systematic review.

Chhajed R. et al, (2024), Lancet Reg Health Southeast Asia, 22

A randomised controlled trial to compare the efficacy, safety, and tolerability of low dose, short course primaquine in adults with uncomplicated P. vivax malaria in two hospitals in India.

Ahmad SS. et al, (2024), Trials, 25

Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis.

Commons RJ. et al, (2024), Lancet Infect Dis, 24, 172 - 183

Load More

Include forthcoming?